Long-term Results of the Stapled Transanal Rectal Resection (STARR) Operation Proposed in the Treatment of a Rectocele (STARRLOC)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT05037422 |
Recruitment Status :
Recruiting
First Posted : September 8, 2021
Last Update Posted : January 3, 2024
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment |
---|---|
Rectocele; Female | Procedure: STARR surgery |
Study Type : | Observational |
Estimated Enrollment : | 77 participants |
Observational Model: | Other |
Time Perspective: | Other |
Official Title: | Single-center Retrospective Study of the Long-term Results of the Stapled TransAnal Rectal Resection (STARR) Operation Proposed in the Treatment of a Rectocele in Consecutive Patients |
Actual Study Start Date : | October 16, 2021 |
Estimated Primary Completion Date : | October 24, 2024 |
Estimated Study Completion Date : | November 24, 2024 |
- Procedure: STARR surgery
This intervention is carried out under general anesthesia or spinal anesthesia. It consists of the circular resection of the "surplus" of rectal mucosa. Rectal resection and suturing is performed using automatic mechanical forceps introduced through the anus.
- Long term results of the STARR operation. [ Time Frame: 10 years ]Dyschezia postoperatively
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | Female |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Patient operated for rectocele for 10 or more
- Age 18 and over
- Informed patients
Exclusion Criteria:
- Patient objection
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT05037422
Contact: Sandrine BARBOIS, MD | 0033476765526 | sandrinebarbois@yahoo.fr |
France | |
CHU Grenoble Alpes, Service de chirurgie digestive et de l'urgence | Recruiting |
Grenoble, France | |
Contact: Jean-Luc FAUCHERON, PU-PH 33476765371 JLFaucheron@chu-grenoble.fr |
Principal Investigator: | Jean-Luc Faucheron, MD | CHU Grenoble Alpes |
Responsible Party: | University Hospital, Grenoble |
ClinicalTrials.gov Identifier: | NCT05037422 |
Other Study ID Numbers: |
38RC21.144 |
First Posted: | September 8, 2021 Key Record Dates |
Last Update Posted: | January 3, 2024 |
Last Verified: | January 2024 |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Rectocele Rectal Diseases Intestinal Diseases Gastrointestinal Diseases |
Digestive System Diseases Hernia Pathological Conditions, Anatomical |